GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
Condition: Biliary Tract Carcinoma Intervention: Combination Product: Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials